Taltz 80 MG/ML autoinj (2-PK)ML
Ended Awarded
- Contract number
- SPE2DR26FZ4HF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,946
Award facts
- Contract value 100% obligated
- $28,946.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,946.37 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/mL auto-injectors (2-pack) on October 28, 2025, with completion expected by October 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication commonly used to treat autoimmune inflammatory conditions, and the auto-injector formulation enables convenient self-administration for military and federal healthcare beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies globally. The IDC supports critical military healthcare programs across multiple therapeutic domains, including specialty medications, biologics, vaccines, and medical devices, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's selection as a prime vendor reflects its demonstrated capability to meet federal procurement standards and support the Department of Defense's medical supply chain requirements at scale.
Quick answers
Who was awarded contract SPE2DR26FZ4HF?
SPE2DR26FZ4HF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FZ4HF worth?
The government has obligated $28,946 on SPE2DR26FZ4HF.
Is contract SPE2DR26FZ4HF an order under another contract?
Yes. SPE2DR26FZ4HF is a delivery order under SPE2DR25D1050, an indefinite delivery contract.
Was contract SPE2DR26FZ4HF competed?
The extent of competition for SPE2DR26FZ4HF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award